PAB5347
antibody from Abnova Corporation
Targeting: EFNB2
EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PAB5347 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#PAB5347, RRID:AB_1574556
- Product name
- EFNB2 polyclonal antibody
- Antibody type
- Polyclonal
- Description
- Rabbit polyclonal antibody raised against synthetic peptide of EFNB2.
- Storage
- Store at -20°C.Aliquot to avoid repeated freezing and thawing.
Submitted references Structural and biophysical characterization of the EphB4*ephrinB2 protein-protein interaction and receptor specificity.
The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
Chrencik JE, Brooun A, Kraus ML, Recht MI, Kolatkar AR, Han GW, Seifert JM, Widmer H, Auer M, Kuhn P
The Journal of biological chemistry 2006 Sep 22;281(38):28185-92
The Journal of biological chemistry 2006 Sep 22;281(38):28185-92
The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.
Kertesz N, Krasnoperov V, Reddy R, Leshanski L, Kumar SR, Zozulya S, Gill PS
Blood 2006 Mar 15;107(6):2330-8
Blood 2006 Mar 15;107(6):2330-8
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
Noren NK, Lu M, Freeman AL, Koolpe M, Pasquale EB
Proceedings of the National Academy of Sciences of the United States of America 2004 Apr 13;101(15):5583-8
Proceedings of the National Academy of Sciences of the United States of America 2004 Apr 13;101(15):5583-8
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Western blot analysis of extract from HUVEC cells, untreated or treated with Insulin or EGF, using EFNB2 polyclonal antibody (Cat # PAB5347).